Results 371 to 380 of about 7,897,516 (385)

Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

Expert Opinion on Drug Safety, 2017
Yasser Alatawi, R. Hansen
semanticscholar   +1 more source

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

The effects of treatment failure generalize across different routes of drug administration

Science Translational Medicine, 2017
M. Zunhammer, M. Ploner, Charlotte Engelbrecht, J. Bock, S. Kessner, U. Bingel   +5 more
semanticscholar   +1 more source

Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014

Pharmacoepidemiology and Drug Safety, 2016
T. Moore, C. Furberg, D. Mattison, Michael R. Cohen   +3 more
semanticscholar   +1 more source

Silica: A lung carcinogen

Ca-A Cancer Journal for Clinicians, 2014
Kyle Steenland
exaly  

Drug Administration

Medicinal chemistry, 2019
G. Patrick
semanticscholar   +1 more source

Family Support in Advanced Cancer

Ca-A Cancer Journal for Clinicians, 2001
Charles W Given
exaly  

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

Ca-A Cancer Journal for Clinicians, 2014
Giada Bianchi, Federico Gago
exaly  

8U.S. Food and Drug Administration

, 2016
Gregory Dolin
semanticscholar   +1 more source

Molecular cancer prevention: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2015
Kenneth Y Tsai, Powel H Brown, Eva Szabo
exaly